December 30, 2016 10:21 ET
TORONTO, ONTARIO--(Marketwired - Dec. 30, 2016) - Pursuant to an amalgamation agreement with Avagenesis Corp. the common shares of Avapecia Life Sciences Corp. will be delisted at the market close today, December 30, 2016.
The resulting amalgamated company will continue to trade on the TSX Venture Exchange.
Date: Market close, December 30, 2016
Canadian Securities Exchange (CSE)Listings(416) 367-7340Listings@thecse.comwww.thecse.com
See all RSS Newsfeeds